May 2, 2007: Phyton Biotech Acquires Novel Glyco-Engineering Technology, Adds
Enhanced Capacity to Manufacture Therapeutic Proteins

July 28, 2006: Phyton Biotech Signs Development Agreement with Insmed

April 11, 2006: Phyton Biotech, Inc., a DFB Pharmaceuticals Affiliate, Signs Licensing Agreement with DiAthegen LLC to Commercialize Growth Hormone Receptor Antagonist That Treats Acromegaly, Cancer, Diabetes